Matrix Metalloproteinases Are Associated With Increased Blood–Brain Barrier Opening in Vascular Cognitive Impairment
- 1 May 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 42 (5) , 1345-1350
Abstract
Background and Purpose—: Subcortical ischemic vascular disease (SIVD) is a major form of vascular cognitive impairment (VCI) due to small vessel disease. Matrix metalloproteinases (MMPs) are neutral proteases that disrupt the blood–brain barrier and degrade myelin basic protein under conditions of neuroinflammation. Brain tissues and cerebrospinal fluid (CSF) of patients with VCI have increased levels of MMPs. We hypothesized that patients with SIVD have increased MMPs in the CSF, which are associated with increased CSF albumin. Methods—: We studied 60 patients with suspected VCI. Twenty-five were classified as SIVD, whereas other groups included mixed Alzheimer disease and VCI, multiple strokes, and leukoaraiosis when white matter lesions were present and the diagnosis of VCI was uncertain. MMP-2 and MMP-9 in CSF and plasma were measured by gel zymography and indexed to CSF and plasma albumin. MMP-3 activity was measured by fluorescent assay. Results—: We found reduced MMP-2 index ( P P P <0.0005). Conclusions—: Our results support the hypothesis that MMPs are associated with increased CSF albumin and suggest that they may contribute to the pathophysiology of SIVD.Keywords
This publication has 26 references indexed in Scilit:
- Lacunar stroke is associated with diffuse blood–brain barrier dysfunctionAnnals of Neurology, 2009
- Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemiaNeuroscience, 2009
- Modern concept of vascular cognitive impairmentBritish Medical Bulletin, 2007
- Matrix Metalloproteinase-Mediated Disruption of Tight Junction Proteins in Cerebral Vessels is Reversed by Synthetic Matrix Metalloproteinase Inhibitor in Focal Ischemia in RatJournal of Cerebral Blood Flow & Metabolism, 2007
- National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization StandardsStroke, 2006
- Measurement of Gelatinase B (MMP-9) in the Cerebrospinal Fluid of Patients With Vascular Dementia and Alzheimer DiseaseStroke, 2004
- Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia?Stroke, 2003
- White Matter Damage Is Associated With Matrix Metalloproteinases in Vascular DementiaStroke, 2001
- Matrix metalloproteinases degrade myelin basic proteinNeuroscience Letters, 1995
- Clinical diagnosis of Binswanger's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1990